Certive Solutions Inc. (CBP.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 137.87 Thousand USD | 167.07% |
| 2021 | -205.56 Thousand USD | -241.21% |
| 2020 | 145.57 Thousand USD | -34.61% |
| 2019 | 222.64 Thousand USD | 1664.19% |
| 2018 | 12.62 Thousand USD | -91.91% |
| 2017 | 155.97 Thousand USD | -46.77% |
| 2016 | 293 Thousand USD | -82.35% |
| 2015 | 1.65 Million USD | 112.03% |
| 2014 | 782.73 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 29.79 Thousand USD | -74.97% |
| 2023 Q1 | 119.01 Thousand USD | 38.57% |
| 2023 Q3 | 110.11 Thousand USD | 269.6% |
| 2022 Q4 | 85.88 Thousand USD | 23.08% |
| 2022 Q2 | 62.65 Thousand USD | 177.89% |
| 2022 Q3 | 69.77 Thousand USD | 11.36% |
| 2022 FY | 137.87 Thousand USD | 167.07% |
| 2022 Q1 | -80.44 Thousand USD | -109.01% |
| 2021 Q4 | -38.49 Thousand USD | -38.56% |
| 2021 Q1 | -121.15 Thousand USD | -559.06% |
| 2021 FY | -205.56 Thousand USD | -241.21% |
| 2021 Q2 | -18.14 Thousand USD | 85.02% |
| 2021 Q3 | -27.77 Thousand USD | -53.11% |
| 2020 Q4 | -18.38 Thousand USD | -158.1% |
| 2020 Q3 | 31.63 Thousand USD | -20.66% |
| 2020 Q2 | 39.87 Thousand USD | -56.87% |
| 2020 Q1 | 92.44 Thousand USD | 8296.46% |
| 2020 FY | 145.57 Thousand USD | -34.61% |
| 2019 Q3 | 79.31 Thousand USD | -7.51% |
| 2019 Q2 | 85.75 Thousand USD | 51.85% |
| 2019 FY | 222.64 Thousand USD | 1664.19% |
| 2019 Q1 | 56.47 Thousand USD | -81.83% |
| 2019 Q4 | 1101.00 USD | -98.61% |
| 2018 Q3 | -233.72 Thousand USD | -449.03% |
| 2018 Q2 | -42.57 Thousand USD | -94.91% |
| 2018 Q4 | 310.75 Thousand USD | 232.96% |
| 2018 Q1 | -21.84 Thousand USD | -58.35% |
| 2018 FY | 12.62 Thousand USD | -91.91% |
| 2017 Q3 | -34.03 Thousand USD | -130.79% |
| 2017 FY | 155.97 Thousand USD | -46.77% |
| 2017 Q4 | -13.79 Thousand USD | 59.48% |
| 2017 Q2 | 110.55 Thousand USD | 8.11% |
| 2017 Q1 | 102.25 Thousand USD | 109.83% |
| 2016 FY | 293 Thousand USD | -82.35% |
| 2016 Q4 | -1.04 Million USD | -417.02% |
| 2016 Q2 | 410.64 Thousand USD | -28.45% |
| 2016 Q1 | 573.93 Thousand USD | 106.15% |
| 2016 Q3 | 328.07 Thousand USD | -20.11% |
| 2015 FY | 1.65 Million USD | 112.03% |
| 2015 Q2 | 671.21 Thousand USD | 73.28% |
| 2015 Q3 | 322.65 Thousand USD | -51.93% |
| 2015 Q4 | 278.41 Thousand USD | -13.71% |
| 2015 Q1 | 387.35 Thousand USD | -4.11% |
| 2014 Q2 | 22.64 Thousand USD | -97.49% |
| 2014 FY | 782.73 Thousand USD | 0.0% |
| 2014 Q4 | 403.96 Thousand USD | 229.75% |
| 2014 Q3 | 122.5 Thousand USD | 440.96% |
| 2014 Q1 | 903.28 Thousand USD | 5125.25% |
| 2013 Q4 | -17.97 Thousand USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | 18.83 Thousand USD | 0.0% |
| 2013 Q3 | - USD | -100.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AI/ML Innovations Inc. | 294.86 Thousand CAD | 53.242% |
| Diagnamed Holdings Corp. | - CAD | -Infinity% |
| Pangenomic Health Inc. | -681.43 Thousand CAD | 120.233% |
| nDatalyze Corp. | 65.2 Thousand CAD | -111.462% |
| Treatment.Com International Inc. | - CAD | -Infinity% |
| Unidoc Health Corp. | -68.26 Thousand CAD | 301.979% |